83 FR 52843 - Government-Owned Inventions; Availability for Licensing; Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 202 (October 18, 2018)

Page Range		52843-52844
FR Document		2018-22722

The Department of Health and Human Services, National

Federal Register, Volume 83 Issue 202 (Thursday, October 18, 2018)

[Federal Register Volume 83, Number 202 (Thursday, October 18, 2018)]
[Notices]
[Pages 52843-52844]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-22722]



-----------------------------------------------------------------------



DEPARTMENT OF HEALTH AND HUMAN SERVICES



National Institutes of Health




Government-Owned Inventions; Availability for Licensing; 

Correction



AGENCY: National Institutes of Health, HHS.



[[Page 52844]]





ACTION: Notice; correction.



-----------------------------------------------------------------------



SUMMARY: The Department of Health and Human Services, National 

Institutes of Health published a Notice in the Federal Register on 

October 9, 2018. That Notice inadvertently contained an error within 

the SUPPLEMENTARY INFORMATION.



FOR FURTHER INFORMATION CONTACT: Peter Soukas, J.D., 301-594-8730; 

[email protected]. Licensing information and copies of the patent 

applications listed below may be obtained by communicating with the 

indicated licensing contact at the Technology Transfer and Intellectual 

Property Office, National Institute of Allergy and Infectious Diseases, 

5601 Fishers Lane, Rockville, MD, 20852; tel. 301-496-2644. A signed 

Confidential Disclosure Agreement will be required to receive copies of 

unpublished patent applications.



SUPPLEMENTARY INFORMATION: 



Correction



    In the Federal Register of October 9, 2018, in FR Doc. 2018-21764, 

on page 50667, in the first column, correct ``HHS Reference No. E-018-

2018/0'' to read ``HHS Reference No. E-167-2018-0''.



    Dated: October 12, 2018.

Suzanne M. Frisbie,

Deputy Director, Technology Transfer and Intellectual Property Office, 

National Institute of Allergy and Infectious Diseases.

[FR Doc. 2018-22722 Filed 10-17-18; 8:45 am]

 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 202 / Thursday, October 18, 2018 / Notices 52843

Secretary shall submit written requests shortfalls, and redundancies; describe (k) Within 2 years of the date of this
for information to the heads of agencies any challenges to the implementation memorandum, and every 2 years
identified by the Committee as having and execution of the Strategy; and thereafter, Covered Officials shall
responsibilities pertaining to biodefense recommend any necessary updates or review and, as appropriate, revise the
(Covered Officials), including the changes to the Strategy. The Assessment Strategy. The APNSA, acting through
following: shall include an analysis of the extent the NSC staff, shall coordinate the
(i) The Secretary of State; to which current United States development of updates to the Strategy.
(ii) the Secretary of the Treasury; Government resources support the goals The updates to the Strategy shall be
(iii) the Secretary of Defense; and objectives of the Strategy, how submitted to the President through the
(iv) the Attorney General; existing programs and resources could APNSA and, to the extent permitted by
(v) the Secretary of the Interior; be better executed or allocated to align and consistent with applicable law and
(vi) the Secretary of Agriculture; with the Strategy, and how additional policy, released to the public.
(vii) the Secretary of Commerce; resources could, if available, be applied (l) The APNSA, with the approval of
(viii) the Secretary of Labor; to support the goals of the Strategy. The every member of the Committee, may
(ix) the Secretary of Health and Team shall coordinate the Assessment designate a different member of the
Human Services; with the NSC staff and the OMB prior Committee to serve as Chair of the
(x) the Secretary of Transportation; to its finalization. The Assessment shall Committee and perform the
(xi) the Secretary of Energy; be submitted to the Committee for responsibilities specified in subsection
(xii) the Secretary of Veterans Affairs; approval and provided to the APNSA 2(c).
(xiii) the Secretary of Homeland and the Director of the OMB within 180 Sec. 3. Earlier Presidential Actions. (a)
Security; days of the formation of the Team and Presidential Policy Directive–2 of
(xiv) the Administrator of the annually thereafter. November 23, 2009 (Implementation of
Environmental Protection Agency; (h) Each year, within 90 days of the the National Strategy for Countering
(xv) the Director of National approval of the Assessment, the Team Biological Threats) and HSPD 10/
Intelligence; shall summarize the Assessment and National Security Presidential Directive-
(xvi) the Administrator of the United prepare, subject to the approval of the 33 of April 21, 2004 (National Policy for
States Agency for International Committee and in coordination with the Biodefense) are hereby superseded and
Development; and NSC staff, a public report describing the
(xvii) the Director of the Federal replaced.
actions taken to reduce the risk of Sec. 4. General Provisions. (a) Nothing
Bureau of Investigation. biological threats to the American in this memorandum shall be construed
(f) These requests shall ask how people. to impair or otherwise affect:
agency programs and activities (i) Each year, Covered Officials, in (i) The authority granted by law to an
contribute to the objectives of the coordination with the APNSA through executive department or agency, or the
Strategy. Covered Officials shall the NSPM–4 process, shall prepare joint head thereof; or
respond to these requests within 60 policy guidance (Guidance) on priority (ii) the functions of the Director of the
days of receipt of the request through a areas of biodefense. The Guidance shall OMB relating to budgetary,
Biodefense Memorandum, as described be informed by the Assessment, and administrative, or legislative proposals.
in paragraphs (i)–(ii) of this subsection. Covered Officials shall consider the (b) This memorandum shall be
(i) The Biodefense Memorandum shall Guidance when they develop their implemented consistent with applicable
identify those activities, programs, and annual budget requests. Based on the laws and subject to the availability of
projects that are planned, programmed, Guidance, the Covered Officials shall appropriations.
or have been executed that advance or include in their respective annual (c) This memorandum is not intended
are expected to advance the Strategy; budget requests to the OMB information to, and does not, create any right or
quantify, to the extent feasible, on the programs within the budget benefit, substantive or procedural,
resources allocated to biodefense within requests that support the enforceable at law or in equity by any
the agency; assess the extent to which implementation of the Strategy and party against the United States, its
the goals, objectives, and sub-objectives conform to budget formulation departments, agencies, or entities, its
of the Strategy are being met; and requirements established by the OMB, officers, employees, or agents, or any
identify impediments to timely and including specified funding levels. other person.
effective implementation and options Concurrently, Covered Officials shall (d) The Secretary is hereby authorized
for their resolution. Each agency shall submit a memorandum to the NSC staff and directed to publish this
provide its Biodefense Memorandum to and the OMB conveying their response memorandum in the Federal Register.
the Committee, the Team, the National to the policy Guidance. Covered
Dated: October 12, 2018.
Security Council (NSC) staff, and the Officials shall ensure that new and
Office of Management and Budget Alex M. Azar II,
existing activities are prioritized and
(OMB). The Team shall distribute the can be accommodated within budget Secretary.
collected Memoranda to Covered guidance from the OMB. [FR Doc. 2018–22742 Filed 10–17–18; 8:45 am]
Officials. (j) Within 120 days of the issuance of BILLING CODE P
(ii) Covered Officials are not required this memorandum, the Team, in
to provide information on specific law coordination with the NSC staff through
enforcement activities, the NSPM–4 process, shall develop a DEPARTMENT OF HEALTH AND
counterproliferation activities, military proposal for metrics, milestones, end HUMAN SERVICES
khammond on DSK30JT082PROD with NOTICES

plans or operations, intelligence states, and roles and responsibilities of
activities, or criminal investigations. agencies, with respect to biodefense National Institutes of Health
(g) The Team, as informed by each activities, particularly in meeting the
Government-Owned Inventions;
Biodefense Memorandum and goals, objectives, and sub-objectives of
Availability for Licensing; Correction
consultations with the agencies, shall the Strategy. This proposal will be
prepare a Biodefense Assessment approved by Deputies, consistent with AGENCY: National Institutes of Health,
(Assessment) to identify any gaps, the NSPM–4 process. HHS.

VerDate Sep<11>2014 17:28 Oct 17, 2018 Jkt 247001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\18OCN1.SGM 18OCN1

52844 Federal Register / Vol. 83, No. 202 / Thursday, October 18, 2018 / Notices

ACTION: Notice; correction. Conflict: Animal Models of Epilepsy, Stroke Health, 6701 Rockledge Drive, Room 3141,
and Spinal Cord Injury. Bethesda, MD 20892, 301–827–7245,
SUMMARY: The Department of Health and Date: October 31, 2018. yuanx4@csr.nih.gov.
Human Services, National Institutes of Time: 11:00 a.m. to 2:00 p.m. Name of Committee: Center for Scientific
Health published a Notice in the Agenda: To review and evaluate grant Review Special Emphasis Panel; PAR Panel:
applications. Decision Making and Emotion Function in
Federal Register on October 9, 2018.
Place: National Institutes of Health, 6701 Aging and AD.
That Notice inadvertently contained an Rockledge Drive, Bethesda, MD 20892 Date: November 13, 2018.
error within the SUPPLEMENTARY (Telephone Conference Call). Time: 11:00 a.m. to 4:00 p.m.
INFORMATION. Contact Person: Paula Elyse Schauwecker, Agenda: To review and evaluate grant
Ph.D., Scientific Review Officer, National applications.
FOR FURTHER INFORMATION CONTACT:
Institutes of Health, Center for Scientific Place: National Institutes of Health, 6701
Peter Soukas, J.D., 301–594–8730; Review, 6701 Rockledge Drive, Room 5211, Rockledge Drive, Bethesda, MD 20892
peter.soukas@nih.gov. Licensing Bethesda, MD 20892, 301–760–8207, (Virtual Meeting).
information and copies of the patent schauweckerpe@csr.nih.gov. Contact Person: Biao Tian, Ph.D., Scientific
applications listed below may be Name of Committee: Center for Scientific Review Officer, Center for Scientific Review,
obtained by communicating with the Review Special Emphasis Panel; PAR— National Institutes of Health, 6701 Rockledge
indicated licensing contact at the Shared Instrumentation: Flow Cytometry. Drive, Room 3089B, MSC 7848, Bethesda,
Technology Transfer and Intellectual Date: November 6, 2018. MD 20892, (301) 402–4411, tianbi@
Property Office, National Institute of Time: 10:00 a.m. to 6:00 p.m. csr.nih.gov.
Allergy and Infectious Diseases, 5601 Agenda: To review and evaluate grant Name of Committee: Center for Scientific
Fishers Lane, Rockville, MD, 20852; tel. applications. Review Special Emphasis Panel; Small
Place: National Institutes of Health, 6701 Business: Non-HIV Anti-Infective
301–496–2644. A signed Confidential
Rockledge Drive, Bethesda, MD 20892 Therapeutics.
Disclosure Agreement will be required (Virtual Meeting). Date: November 14–15, 2018.
to receive copies of unpublished patent Contact Person: John Burch, Ph.D., Time: 8:00 a.m. to 5:00 p.m.
applications. Scientific Review Officer, Center for Agenda: To review and evaluate grant
SUPPLEMENTARY INFORMATION: Scientific Review, National Institute of applications.
Health, 6701 Rockledge Drive, Room 3213, Place: Cambria Hotel Rockville, 1 Helen
Correction MSC 7808, Bethesda, MD 20892, 301–408– Heneghan Way, Rockville, MD 20850.
9519, burchjb@csr.nih.gov. Contact Person: Neerja Kaushik-Basu,
In the Federal Register of October 9,
Name of Committee: Center for Scientific Ph.D., Scientific Review Officer, Center for
2018, in FR Doc. 2018–21764, on page Scientific Review, National Institutes of
50667, in the first column, correct ‘‘HHS Review Special Emphasis Panel; Eye function
Assessments, Genetics and Interventions. Health, 6701 Rockledge Drive, Room 3198,
Reference No. E–018–2018/0’’ to read Date: November 7, 2018. MSC 7808, Bethesda, MD 20892, (301) 435–
‘‘HHS Reference No. E–167–2018–0’’. Time: 10:30 a.m. to 12:30 p.m. 2306, kaushikbasun@csr.nih.gov.
Dated: October 12, 2018. Agenda: To review and evaluate grant Name of Committee: Center for Scientific
Suzanne M. Frisbie, applications. Review Special Emphasis Panel; Small
Place: National Institutes of Health, 6701 Business: Cell and Molecular Biology.
Deputy Director, Technology Transfer and Date: November 14–15, 2018.
Rockledge Drive, Bethesda, MD 20892
Intellectual Property Office, National Institute Time: 8:00 a.m. to 5:00 p.m.
(Telephone Conference Call).
of Allergy and Infectious Diseases. Agenda: To review and evaluate grant
Contact Person: Alessandra C. Rovescalli,
[FR Doc. 2018–22722 Filed 10–17–18; 8:45 am] Ph.D., Scientific Review Officer, National applications.
BILLING CODE 4140–01–P Institutes of Health, Center for Scientific Place: Hotel Nikko San Francisco, 222
Review, 6701 Rockledge Drive, Rm 5205, Mason Street, San Francisco, CA 94102.
MSC 7846, Bethesda, MD 20892, (301) 435– Contact Person: Amy Kathleen Wernimont,
DEPARTMENT OF HEALTH AND 1021, rovescaa@mail.nih.gov. Ph.D., Scientific Review Officer, Center for
HUMAN SERVICES Name of Committee: Center for Scientific Scientific Review, National Institutes of
Review Special Emphasis Panel; Small Health, 6701 Rockledge Drive, Room 6198,
National Institutes of Health Business: Biomaterials, Delivery and Bethesda, MD 20892, 301–827–6427,
Nanotechnology. amy.wernimont@nih.gov.
Center for Scientific Review; Notice of Date: November 13, 2018. Name of Committee: Center for Scientific
Closed Meetings Time: 8:00 a.m. to 6:00 p.m. Review Special Emphasis Panel; Member
Agenda: To review and evaluate grant Conflict: Pain Mechanisms.
Pursuant to section 10(d) of the applications. Date: November 14–15, 2018.
Federal Advisory Committee Act, as Place: Hilton Washington/Rockville, 1750 Time: 8:00 a.m. to 6:00 p.m.
amended, notice is hereby given of the Rockville Pike, Rockville, MD 20852. Agenda: To review and evaluate grant
following meetings. Contact Person: Nitsa Rosenzweig, Ph.D., applications.
Scientific Review Officer, Center for Place: National Institutes of Health, 6701
The meetings will be closed to the
Scientific Review, National Institutes of Rockledge Drive, Bethesda, MD 20892
public in accordance with the Health, 6701 Rockledge Drive, Room 4152, (Virtual Meeting).
provisions set forth in sections MSC 7760, Bethesda, MD 20892, (301) 404– Contact Person: John Bishop, Ph.D.,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 7419, rosenzweign@csr.nih.gov. Scientific Review Officer, Center for
as amended. The grant applications and Name of Committee: Center for Scientific Scientific Review, National Institutes of
the discussions could disclose Review Special Emphasis Panel; Small Health, 6701 Rockledge Drive, Room 5182,
confidential trade secrets or commercial Business: Health Informatics. MSC 7844, Bethesda, MD 20892, (301) 408–
property such as patentable material, Date: November 13–14, 2018. 9664, bishopj@csr.nih.gov.
khammond on DSK30JT082PROD with NOTICES

and personal information concerning Time: 8:00 a.m. to 6:00 p.m. Name of Committee: Center for Scientific
individuals associated with the grant Agenda: To review and evaluate grant Review Special Emphasis Panel; Member
applications, the disclosure of which applications. Conflict: Topics in Bacterial Pathogenesis
Place: The William F. Bolger Center, 9600 and Host Interactions.
would constitute a clearly unwarranted
Newbridge Drive, Potomac, MD 20854. Date: November 14, 2018.
invasion of personal privacy. Contact Person: Xin Yuan, MD, Ph.D., Time: 9:30 a.m. to 5:00 p.m.
Name of Committee: Center for Scientific Scientific Review Officer, Center for Agenda: To review and evaluate grant
Review Special Emphasis Panel; Member Scientific Review, National Institutes of applications.

VerDate Sep<11>2014 17:28 Oct 17, 2018 Jkt 247001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\18OCN1.SGM 18OCN1

Document Created: 2018-10-18 03:05:33
Document Modified: 2018-10-18 03:05:33

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice; correction.
Contact		Peter Soukas, J.D., 301-594-8730;
FR Citation		83 FR 52843

83 FR 52843 - Government-Owned Inventions; Availability for Licensing; Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 202 (October 18, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health